• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Necrostatin-1 通过抑制受体相互作用蛋白 1 减轻大鼠皮瓣模型的缺血再灌注损伤。

Necrostatin-1 protects against ischemia/reperfusion injury by inhibiting receptor-interacting protein 1 in a rat flap model.

机构信息

Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing, China; Chiese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing, China.

出版信息

J Plast Reconstr Aesthet Surg. 2019 Feb;72(2):194-202. doi: 10.1016/j.bjps.2018.10.019. Epub 2018 Nov 19.

DOI:10.1016/j.bjps.2018.10.019
PMID:30509738
Abstract

INTRODUCTION

The failure of reconstructive surgeries remains a challenge for plastic surgeons. Ischemia reperfusion (I/R) injury is considered to be one of the major problems in flap surgery. Necroptosis is a recently discovered and caspase-3-independent programed necrosis. Necrostatin-1 (Nec-1) is a specific inhibitor of necroptosis. Reports indicate that Nec-1 provides protection in ischemic models, such as brain, kidney, and heart. The aim of this study is to investigate the influence of Nec-1 on the I/R process in rat abdominal skin flaps.

METHODS

Twenty male Sprague-Dawley rats, weighing 280-320 g, were randomly divided into three groups. The extended epigastric skin flap (6 cm × 9 cm) of rats was used. Three hours of complete ischemia was performed using a clamp, and the clamp was then removed to reperfusion the flap. Twenty-four hours after the onset of the reperfusion, the rats were assessed for flap survival and perfusion analysis. One sample (1 cm × 1 cm) was taken for H&E, TUNEL, electron microscopy, IHC staining for RIP-1, and ELISA analysis for caspase-3 activity.

RESULTS

Compared to the CTL group, the flap in the Nec-1 group showed a higher survival rate and better blood perfusion. In histological observation, skin flap in the Nec-1 group showed less inflammatory infiltration than the CTL group. The AI in the CTL group was higher than that in the Nec-1 group and showed typical morphological changes of apoptotic cells. In IHC study, RIP-1 expression was higher in the CTL group. But there was no significant difference between the two groups in caspase-3 activity detection.

CONCLUSION

Nec-1 has a protective effect against I/R injury through the inhibition of RIP-1 on the skin flap model; this makes it a promising novel strategy in clinical setting.

摘要

简介

重建手术的失败仍然是整形外科医生面临的挑战。缺血再灌注(I/R)损伤被认为是皮瓣手术中的主要问题之一。坏死性凋亡是一种新发现的、不依赖于半胱天冬酶-3 的程序性细胞坏死。坏死抑制剂-1(Nec-1)是坏死性凋亡的特异性抑制剂。有报道称,Nec-1 可在脑、肾和心脏等缺血模型中提供保护。本研究旨在探讨 Nec-1 对大鼠腹部皮瓣 I/R 过程的影响。

方法

20 只雄性 Sprague-Dawley 大鼠,体重 280-320g,随机分为三组。采用大鼠扩展上腹皮瓣(6cm×9cm)。用夹具夹闭 3 小时造成完全缺血,然后松开夹具再灌注皮瓣。再灌注 24 小时后,评估皮瓣存活和灌注情况。取 1 个样本(1cm×1cm)用于 H&E、TUNEL、电镜、RIP-1 的 IHC 染色和 caspase-3 活性的 ELISA 分析。

结果

与 CTL 组相比,Nec-1 组的皮瓣存活率更高,血供更好。组织学观察显示,Nec-1 组皮瓣的炎症浸润较 CTL 组少。CTL 组的 AI 高于 Nec-1 组,且出现典型的凋亡细胞形态学改变。在 IHC 研究中,CTL 组的 RIP-1 表达较高,但两组间 caspase-3 活性检测无明显差异。

结论

Nec-1 通过抑制 RIP-1 对皮瓣模型发挥 I/R 损伤保护作用;这使其成为临床有前途的新策略。

相似文献

1
Necrostatin-1 protects against ischemia/reperfusion injury by inhibiting receptor-interacting protein 1 in a rat flap model.Necrostatin-1 通过抑制受体相互作用蛋白 1 减轻大鼠皮瓣模型的缺血再灌注损伤。
J Plast Reconstr Aesthet Surg. 2019 Feb;72(2):194-202. doi: 10.1016/j.bjps.2018.10.019. Epub 2018 Nov 19.
2
Necroptosis was found in a rat ischemia/reperfusion injury flap model.在大鼠缺血/再灌注损伤皮瓣模型中发现了细胞坏死性凋亡。
Chin Med J (Engl). 2019 Jan 5;132(1):42-50. doi: 10.1097/CM9.0000000000000005.
3
Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats.Necrostatin-1 与泛半胱天冬酶抑制剂协同作用减轻大鼠缺血再灌注肺损伤。
Mediators Inflamm. 2020 Oct 24;2020:7059304. doi: 10.1155/2020/7059304. eCollection 2020.
4
Rip 1-dependent endothelial necroptosis participates in ischemia-reperfusion injury of mouse flap.Rip1 依赖性内皮细胞坏死参与了小鼠皮瓣缺血再灌注损伤。
J Dermatol Sci. 2020 Jan;97(1):30-40. doi: 10.1016/j.jdermsci.2019.11.009. Epub 2019 Nov 28.
5
Inhibition of regulated necrosis attenuates receptor-interacting protein kinase 1-mediated ischemia-reperfusion injury after lung transplantation.抑制调节性细胞坏死可减轻肺移植后受体相互作用蛋白激酶 1 介导的缺血再灌注损伤。
J Heart Lung Transplant. 2018 Oct;37(10):1261-1270. doi: 10.1016/j.healun.2018.04.005. Epub 2018 Apr 26.
6
Ischemia Reperfusion Injury Triggers TNFα Induced-Necroptosis in Rat Retina.缺血再灌注损伤引发大鼠视网膜中肿瘤坏死因子α诱导的坏死性凋亡。
Curr Eye Res. 2017 May;42(5):771-779. doi: 10.1080/02713683.2016.1227449. Epub 2016 Oct 12.
7
Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury.受体相互作用蛋白3上调及核转位的抑制参与Necrostatin-1对缺血/再灌注损伤诱导的海马神经元程序性坏死的保护作用。
Brain Res. 2015 Jun 3;1609:63-71. doi: 10.1016/j.brainres.2015.03.024. Epub 2015 Mar 20.
8
Extracorporeal shock wave treatment protects skin flaps against ischemia-reperfusion injury.体外冲击波治疗可保护皮瓣免受缺血再灌注损伤。
Injury. 2012 Mar;43(3):374-80. doi: 10.1016/j.injury.2011.11.019. Epub 2011 Dec 18.
9
Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.坏死性凋亡和凋亡抑制的联合作用增强了对心肌缺血再灌注损伤的心脏保护作用。
J Anesth. 2014 Apr;28(2):235-41. doi: 10.1007/s00540-013-1716-3. Epub 2013 Oct 11.
10
Methane-rich saline attenuates ischemia/reperfusion injury of abdominal skin flaps in rats via regulating apoptosis level.富含甲烷的盐水通过调节细胞凋亡水平减轻大鼠腹部皮瓣的缺血/再灌注损伤。
BMC Surg. 2015 Jul 31;15:92. doi: 10.1186/s12893-015-0075-4.

引用本文的文献

1
Targeting Programmed Cell Death in Flap Ischemia/Reperfusion Injury.针对皮瓣缺血/再灌注损伤中的程序性细胞死亡
Biomolecules. 2025 Jun 20;15(7):911. doi: 10.3390/biom15070911.
2
Necrostatin-1: a promising compound for neurological disorders.坏死抑制因子-1:一种治疗神经疾病的有前景的化合物。
Front Cell Neurosci. 2024 Jun 27;18:1408364. doi: 10.3389/fncel.2024.1408364. eCollection 2024.
3
PTPMT1 protects cardiomyocytes from necroptosis induced by γ-ray irradiation through alleviating mitochondria injury.PTPMT1 通过减轻线粒体损伤保护心肌细胞免受 γ 射线照射诱导的坏死性凋亡。
Am J Physiol Cell Physiol. 2023 Jun 1;324(6):C1320-C1331. doi: 10.1152/ajpcell.00466.2022. Epub 2023 May 8.
4
Necroptosis in CNS diseases: Focus on astrocytes.中枢神经系统疾病中的坏死性凋亡:聚焦于星形胶质细胞。
Front Aging Neurosci. 2023 Jan 27;14:1016053. doi: 10.3389/fnagi.2022.1016053. eCollection 2022.
5
Targeting necroptosis as therapeutic potential in chronic myocardial infarction.靶向坏死性凋亡作为慢性心肌梗死的治疗潜力。
J Biomed Sci. 2021 Apr 9;28(1):25. doi: 10.1186/s12929-021-00722-w.
6
Mitochondrial quality control mechanisms as molecular targets in cardiac ischemiareperfusion injury.线粒体质量控制机制作为心脏缺血再灌注损伤的分子靶点
Acta Pharm Sin B. 2020 Oct;10(10):1866-1879. doi: 10.1016/j.apsb.2020.03.004. Epub 2020 Apr 8.
7
Evidence of necroptosis in osteoarthritic disease: investigation of blunt mechanical impact as possible trigger in regulated necrosis.骨关节炎疾病中坏死性凋亡的证据:钝性机械冲击作为调节性细胞坏死可能触发因素的研究。
Cell Death Dis. 2019 Sep 17;10(10):683. doi: 10.1038/s41419-019-1930-5.